DAB2IP and neoplasm: It would be interesting to test whether the tumor-suppressive effects of mutp53 inhibitors are at least in part mediated by DAB2IP, and/or whether DAB2IP stabilizing agents could increase the anti-tumoral effects of mutp53-targeting drugs (Table 2).